Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway

Hyunsook An, Ji Young Kim, Nahyun Lee, Youngkwan Cho, Eunhye Oh, Jae Hong Seo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) play important roles in the formation, growth and recurrence of tumors, particularly following therapeutic intervention. Salinomycin has received recent attention for its ability to target breast cancer stem cells (BCSCs), but the mechanisms of action involved are not fully understood. In the present study, we sought to investigate the mechanisms responsible for salinomycin's selective targeting of BCSCs and its anti-tumor activity. Salinomycin suppressed cell viability, concomitant with the downregulation of cyclin D1 and increased p27kip1 nuclear accumulation. Mammosphere formation assays revealed that salinomycin suppresses self-renewal of ALDH1-positive BCSCs and downregulates the transcription factors Nanog, Oct4 and Sox2. TUNEL analysis of MDA-MB-231-derived xenografts revealed that salinomycin administration elicited a significant reduction in tumor growth with a marked downregulation of ALDH1 and CD44 levels, but seemingly without the induction of apoptosis. Our findings shed further light on the mechanisms responsible for salinomycin's effects on BCSCs.

Original languageEnglish
Pages (from-to)696-703
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume466
Issue number4
DOIs
Publication statusPublished - 2015 Oct 30

Fingerprint

Neoplastic Stem Cells
Tumors
Stem cells
Apoptosis
Breast Neoplasms
Neoplasms
Down-Regulation
Cyclin D1
In Situ Nick-End Labeling
Growth
Heterografts
salinomycin
Assays
Cell Survival
Transcription Factors
Cells
Recurrence

Keywords

  • ALDH1
  • Breast cancer stem cells
  • Mammosphere
  • Salinomycin

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway. / An, Hyunsook; Kim, Ji Young; Lee, Nahyun; Cho, Youngkwan; Oh, Eunhye; Seo, Jae Hong.

In: Biochemical and Biophysical Research Communications, Vol. 466, No. 4, 30.10.2015, p. 696-703.

Research output: Contribution to journalArticle

@article{9baa1e559480477fb497d9d60e675ad9,
title = "Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway",
abstract = "Cancer stem cells (CSCs) play important roles in the formation, growth and recurrence of tumors, particularly following therapeutic intervention. Salinomycin has received recent attention for its ability to target breast cancer stem cells (BCSCs), but the mechanisms of action involved are not fully understood. In the present study, we sought to investigate the mechanisms responsible for salinomycin's selective targeting of BCSCs and its anti-tumor activity. Salinomycin suppressed cell viability, concomitant with the downregulation of cyclin D1 and increased p27kip1 nuclear accumulation. Mammosphere formation assays revealed that salinomycin suppresses self-renewal of ALDH1-positive BCSCs and downregulates the transcription factors Nanog, Oct4 and Sox2. TUNEL analysis of MDA-MB-231-derived xenografts revealed that salinomycin administration elicited a significant reduction in tumor growth with a marked downregulation of ALDH1 and CD44 levels, but seemingly without the induction of apoptosis. Our findings shed further light on the mechanisms responsible for salinomycin's effects on BCSCs.",
keywords = "ALDH1, Breast cancer stem cells, Mammosphere, Salinomycin",
author = "Hyunsook An and Kim, {Ji Young} and Nahyun Lee and Youngkwan Cho and Eunhye Oh and Seo, {Jae Hong}",
year = "2015",
month = "10",
day = "30",
doi = "10.1016/j.bbrc.2015.09.108",
language = "English",
volume = "466",
pages = "696--703",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "4",

}

TY - JOUR

T1 - Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway

AU - An, Hyunsook

AU - Kim, Ji Young

AU - Lee, Nahyun

AU - Cho, Youngkwan

AU - Oh, Eunhye

AU - Seo, Jae Hong

PY - 2015/10/30

Y1 - 2015/10/30

N2 - Cancer stem cells (CSCs) play important roles in the formation, growth and recurrence of tumors, particularly following therapeutic intervention. Salinomycin has received recent attention for its ability to target breast cancer stem cells (BCSCs), but the mechanisms of action involved are not fully understood. In the present study, we sought to investigate the mechanisms responsible for salinomycin's selective targeting of BCSCs and its anti-tumor activity. Salinomycin suppressed cell viability, concomitant with the downregulation of cyclin D1 and increased p27kip1 nuclear accumulation. Mammosphere formation assays revealed that salinomycin suppresses self-renewal of ALDH1-positive BCSCs and downregulates the transcription factors Nanog, Oct4 and Sox2. TUNEL analysis of MDA-MB-231-derived xenografts revealed that salinomycin administration elicited a significant reduction in tumor growth with a marked downregulation of ALDH1 and CD44 levels, but seemingly without the induction of apoptosis. Our findings shed further light on the mechanisms responsible for salinomycin's effects on BCSCs.

AB - Cancer stem cells (CSCs) play important roles in the formation, growth and recurrence of tumors, particularly following therapeutic intervention. Salinomycin has received recent attention for its ability to target breast cancer stem cells (BCSCs), but the mechanisms of action involved are not fully understood. In the present study, we sought to investigate the mechanisms responsible for salinomycin's selective targeting of BCSCs and its anti-tumor activity. Salinomycin suppressed cell viability, concomitant with the downregulation of cyclin D1 and increased p27kip1 nuclear accumulation. Mammosphere formation assays revealed that salinomycin suppresses self-renewal of ALDH1-positive BCSCs and downregulates the transcription factors Nanog, Oct4 and Sox2. TUNEL analysis of MDA-MB-231-derived xenografts revealed that salinomycin administration elicited a significant reduction in tumor growth with a marked downregulation of ALDH1 and CD44 levels, but seemingly without the induction of apoptosis. Our findings shed further light on the mechanisms responsible for salinomycin's effects on BCSCs.

KW - ALDH1

KW - Breast cancer stem cells

KW - Mammosphere

KW - Salinomycin

UR - http://www.scopus.com/inward/record.url?scp=84943233240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943233240&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2015.09.108

DO - 10.1016/j.bbrc.2015.09.108

M3 - Article

VL - 466

SP - 696

EP - 703

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 4

ER -